Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials by McNeil Ngongondo, Justin Ritz, Michael D. Hughes, Mitch Matoga, Mina C. Hosseinipour

Connect to this object online.

Qualitative interviews to evaluate content validity of the ACTIV-2 COVID-19 Symptom Diary (ACSD) by Louis S. Matza, Katie D. Stewart, April N. Naegeli, Kayla M. Mills, Karin S. Coyne, Kara W. Chew, Michael D. Hughes, Davey M. Smith

Connect to this object online.

Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials. by McNeil Ngongondo, Justin Ritz, Michael D Hughes, Mitch Matoga, Mina C Hosseinipour, AIDS Clinical Trials Group A5208, A5221, A5175 and A5274 Study Teams

Connect to this object online.

Similar HIV protection from four weeks of zidovudine versus nevirapine prophylaxis among formula-fed infants in Botswana by Kathleen M. Powis, Shahin Lockman, Gbolahan Ajibola, Michael D. Hughes, Kara Bennett, Jean Leidner, Oganne Batlang, Kerapetse Botebele, Sikhulile Moyo, Erik van Widenfelt, Joseph Makhema, Chipo Petlo, Haruna B. Jibril, Kenneth McIntosh, Max Essex, Roger L. Shapiro

Connect to this object online.